Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Growth hormone-releasing hormone receptor (GHRH-R)

Review Growth hormone-releasing hormone receptor (GHRH-R) and its signaling Gabor Halmos et al. Rev Endocr Metab Disord. 2025 Jun. Abstract The hypothalamic polypeptide growth hormone-releasing hormone (GHRH) stimulates the secretion of growth hormone (GH) from the pituitary through binding and activation of the pituitary type of GHRH receptor (GHRH-R), which belongs to the family of G protein-coupled receptors with seven potential membrane-spanning domains. Various splice variants of GHRH-R (SV) in human neoplasms and other extrapituitary tissues were demonstrated and their cDNA was sequenced. Among the SVs, splice variant 1 (SV1) possesses the greatest similarity to the full-length GHRH-R and remains functional by eliciting cAMP signaling and mitogenic activity upon stimulation by GHRH. In this review, we briefly discuss the activation, regulation, molecular mechanisms and signaling pathways of GHRH-Rs and their SVs in various tissues and also summarize the expression, biological act

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Review

Growth hormone-releasing hormone receptor (GHRH-R) and its signaling

Gabor Halmos et al. Rev Endocr Metab Disord. 2025 Jun.

Abstract

The hypothalamic polypeptide growth hormone-releasing hormone (GHRH) stimulates the secretion of growth hormone (GH) from the pituitary through binding and activation of the pituitary type of GHRH receptor (GHRH-R), which belongs to the family of G protein-coupled receptors with seven potential membrane-spanning domains. Various splice variants of GHRH-R (SV) in human neoplasms and other extrapituitary tissues were demonstrated and their cDNA was sequenced. Among the SVs, splice variant 1 (SV1) possesses the greatest similarity to the full-length GHRH-R and remains functional by eliciting cAMP signaling and mitogenic activity upon stimulation by GHRH. In this review, we briefly discuss the activation, regulation, molecular mechanisms and signaling pathways of GHRH-Rs and their SVs in various tissues and also summarize the expression, biological activities and potential function of GHRH, its analogs and their receptors. A large body of work have extensively studied and evaluated potential clinical applications of agonists and antagonists of GHRH in diverse fields, including oncology, endocrinology, obesity, diabetes, other metabolic dysfunctions, cardiology, immune functions, mood disorders, Alzheimer's and lung disease, ophthalmology, inflammation, wound healing and other applications. These results strongly support the potential therapeutic use of GHRH analogs in human medicine in the near future.

Keywords: GHRH receptor (GHRH-R); Growth hormone-releasing hormone (GHRH); Signalization; Splice variants (SVs).

© 2025. The Author(s).

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures Fig. 1

Amino acid sequences of human GHRH (GHRH 1–44). The full biological activity is retained in the N-terminal 29 amino acid sequence [GHRH(1–29)NH2] Fig. 2

Schematic drawing and summary diagram of the potential role and signaling mechanisms, cascades and cellular effects of GHRH, GHRH agonists and GHRH antagonists mediated by GHRH-R and SV1

References

Cong Z, et al. Constitutive signal bias mediated by the human GHRHR splice variant 1. Proc Natl Acad Sci U S A. 2021;118(40). 10.1073/pnas.2106606118. - PMC - PubMed

Halmos G et al. Hypothalamic Releasing Hormones in Hormonal Signaling in Biology and Medicine: Comprehensive modern endocrinology. Ed. Litwack Gerald, Academic Press. London 4368-, 2019. ISBN 9780128138144.

Granata R, et al. Growth hormone-releasing hormone and its analogues in health and disease. Nat Rev Endocrinol. 2024. 10.1038/s41574-024-01052-1. - DOI - PubMed

Mayo KE, et al. International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev. 2003;55(1):167–94. 10.1124/pr.55.1.6. - DOI - PubMed

DeAlmeida VI, Mayo KE. Identification of binding domains of the growth hormone-releasing hormone receptor by analysis of mutant and chimeric receptor proteins. Mol Endocrinol. 1998;12(5):750–65. 10.1210/mend.12.5.0102. - DOI - PubMed

Connected topics

Follow this recovery question